1,3,5-Triazine-2,4,6-Triamine Compound or Pharmaceutical Acceptable Salt Thereof, and Pharmaceutical Composition Comprising the Same
申请人:Cheon Hyae Gyeong
公开号:US20110237587A1
公开(公告)日:2011-09-29
Disclosed herein are a 1,3,5-triazine-2,4,6-triamine compound or a pharmaceutically acceptable salt thereof, a preparation method thereof, and a composition for preventing or treating metabolic syndromes, diabetes, or cancers with deletion of P53 gene, which comprises the same.
1,3,5-TRIAZINE-2,4,6-TRIAMINE COMPOUND OR PHARMACEUTICAL ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
申请人:Hanall Pharmaceutical Company Ltd
公开号:EP2197858A2
公开(公告)日:2010-06-23
[EN] 1,3,5-TRIAZINE-2,4,6-TRIAMINE COMPOUND OR PHARMACEUTICAL ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME<br/>[FR] COMPOSÉ DE 1,3,5-TRIAZINE-2,4,6-TRIAMINE OU SON SEL PHARMACEUTIQUEMENT ACCEPTABLE, ET COMPOSITION PHARMACEUTIQUE LE COMPRENANT
申请人:HANALL PHARMACEUTICAL CO LTD
公开号:WO2009028891A2
公开(公告)日:2009-03-05
Disclosed herein are a 1,3,5-triazine-2,4,6-triamine compound or a pharmaceutically acceptable salt thereof, a preparation method thereof, and a composition for preventing or treating metabolic syndromes, diabetes, or cancers with deletion of P53 gene, which comprises the same.
Fluorescence and Morphology Modulation in a Photochromic Diarylethene Self-Assembly System
the assembly can be reversibly switched by alternating UV/visible light irradiation. Meanwhile, the morphology of the coassembly of 12·DTE changed to film from original pieces of gel 1 in ethyl acetate. When 12·DTE was irradiated by UV light, the film morphology was converted into aggregated flakes. Moreover, the surfacewettability of the complex can also be switched by light irradiation. The photochromic